Latest Breaking News On - Florian denis - Page 1 : comparemela.com

Drug discovery startup Pepper Bio hopes to challenge Eroom's law with new funding

While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn't getting cheaper. "Today, drug development still takes on average 10-15 years of R&D with a cost of production (around $2.5 billion) that has increased dramatically over the last decade despite improvements in technology: this is the concept of Eroom's law (Moore’s law spelled backwards)," deep tech VC Florian Denis wrote in a recent Medium post. While AI could help uncover new drugs, "the AI analysis is really only as good as the data that you put into it," Pepper Bio CEO Jon Hu told me.

Samantha dale strasserDale strasserFlorian denisStanford felsher labMerck digital sciences studioPepper bioSilverton partnersMana venturesTensility venturesFelsher labDrug developmentDrug discoveryDale strasserPepper

Drug discovery startup Pepper Bio hopes to challenge Eroom's law with new funding

The biotech startup's $6.5 million seed round is led by VC firm NFX but it is perhaps equally noteworthy to see that Merck is also participating in the round.

Dale strasserFlorian denisSamantha dale strasserMerck digital sciences studioStanford felsher labPepper bioSilverton partnersMana venturesTensility venturesFelsher lab

Drug discovery startup Pepper Bio hopes to challenge Eroom's law with new funding

While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn't getting cheaper. "Today, drug development still takes on average 10-15 years of R&D with a cost of production (around $2.5 billion) that has increased dramatically over the last decade despite improvements in technology: this is the concept of Eroom's law (Moore’s law spelled backwards)," deep tech VC Florian Denis wrote in a recent Medium post. While AI could help uncover new drugs, "the AI analysis is really only as good as the data that you put into it," Pepper Bio CEO Jon Hu told me.

Florian denisSamantha dale strasserDale strasserStanford felsher labMerck digital sciences studioPepper bioSilverton partnersMana venturesTensility venturesFelsher lab

Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners | Antibodies

Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners

MilanLombardiaItalyParisFrance generalFranceLondonCity ofUnited kingdomJean guillaume lafayFondation fournier majoieMablink adcsGraziano seghezziMablink biosciencesAlpha fraMablink bioscience

Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Merieux Equity Partners

Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Merieux Equity Partners
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

MilanLombardiaItalyParisFrance generalFranceLondonCity ofUnited kingdomJean guillaume lafayFondation fournier majoieMablink adcsGraziano seghezziAlpha fraMablink bioscienceFlorian denis